Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Open in API
Filings indexed 617 across all filing types
Latest filing 2022-04-05 Capital/Financing Update
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
Informacja o wykonaniu istotnej umowy - Content (PL)
Capital/Financing Update Classification · 99% confidence The document text is very short (274 characters) and announces the completion of a contract ('umowy') that was previously reported (referencing report ESPI nr 5/2022). It states this completion will significantly impact revenues and financial results for the first half of 2022 ('I półrocze 2022 r.'). This is a specific operational update concerning financial impact, but it is not a full financial report (like IR or 10-K), nor is it a standard earnings release (ER) which usually contains summarized figures. It is an announcement regarding a significant event impacting financials. Given the options, this type of specific, material operational update that affects financial outcomes, but isn't a formal financial statement or a standard earnings release, fits best under the general 'Regulatory Filings' (RNS) category as a specific material event disclosure, or potentially a Capital/Financing Update (CAP) if the contract was related to financing, but RNS is the safer general disclosure category when a specific code is missing for material operational news.
2022-04-05 Polish
Rekomendacja zarządu w przedmiocie podziału zysku - Content (PL)
Notice of Dividend Amount Classification · 98% confidence The document text, written in Polish, explicitly states that the Management Board (Zarząd) has resolved to recommend to the General Meeting (Walne Zgromadzenie) a proposal regarding the distribution of profit for 2021. Specifically, it details the recommendation to pay a dividend of PLN 0.45 per share and allocate the remainder to the reserve capital. It also sets proposed dates for determining the right to the dividend and the payment date. This content directly relates to the announcement of dividend amounts and details for shareholders. Therefore, the appropriate classification is 'Notice of Dividend Amount' (DIV). The document is short and contains the core decision, not just an announcement that a report is attached.
2022-03-29 Polish
zwiekszenie_ilosci_28032022.pdf
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction/transactions referred to in Article 19(1) of the MAR Regulation). It details a transaction (Nabycie - Acquisition) of shares by a person discharging managerial responsibilities (Przewodniczący Rady Nadzorczej - Chairman of the Supervisory Board) in the company BioMaxima Spółka Akcyjna. This directly corresponds to the definition of Director's Dealing (insider trades by directors and executives). The relevant code is DIRS.
2022-03-29 Polish
Zawiadomienie od osoby zobowiązanej - Content (PL)
Board/Management Information Classification · 87% confidence The document text is extremely short (132 characters) and states that the Management Board received a notification from Mr. Mariusz Nowak, which is attached to the current report. This structure strongly suggests an announcement about receiving or attaching a document, rather than the document itself. The content mentions a notification received by management, which often relates to insider transactions (Director's Dealing - DIRS) or major shareholdings (MRQ). However, since the text is merely announcing the receipt of an attachment without detailing the transaction or holding, and given its brevity, it fits the 'Report Publication Announcement' (RPA) or a general 'Regulatory Filing' (RNS) best, based on the 'MENU VS MEAL' rule (announcement vs. content). Since the content hints at insider activity (a notification received by management), and DIRS is a specific category for director dealings, I will check if this fits DIRS better than RPA/RNS. A DIRS filing usually contains the details of the transaction. This text only says a notification was received and attached. Given the ambiguity and extreme brevity, classifying it as a general Regulatory Filing (RNS) is the safest fallback, although it could potentially be a very brief DIRS announcement wrapper. Given the context of 'powiadomienie' (notification) received by the board, it is highly likely related to insider activity. If it were a DIRS filing, it would typically contain the details. Since it only announces the receipt of an attachment, RPA or RNS is more appropriate based on the length rule. I will choose RNS as the general regulatory announcement fallback for short notices that don't fit other specific announcement types perfectly.
2022-03-29 Polish
Podpisanie znaczącej umowy - Content (PL)
Regulatory Filings Classification · 99% confidence The document text describes a significant contract signed by the company (BioMaxima S.A.) for the supply of automated cell culture analyzers, detailing the value (3,209,850.00 PLN) and expected recurring revenue (1.5 million PLN annually). This transaction is explicitly stated as 'istotna w zakresie podstawowej działalności Spółki' (significant in relation to the core business). This type of announcement, concerning a major contract or transaction that impacts the company's operations or financial outlook, best fits the 'Capital/Financing Update' (CAP) if it involves fundraising, or more generally, a significant corporate event. However, none of the provided codes perfectly capture a 'Major Contract Award' unless it is related to financing (CAP) or M&A (TAR). Given the context of a major supply agreement that generates significant future revenue, it is a material event. Since it is not a standard regulatory filing like 10-K or ER, and doesn't fit DIRS, DIV, or DLST, I must evaluate the closest fit. A major contract award that doesn't involve share issuance or debt issuance is often classified under general regulatory announcements or sometimes as a material event. Given the options, and assuming this is a material disclosure not covered by other specific codes, 'Regulatory Filings' (RNS) is the most appropriate fallback for a significant, non-standard corporate announcement. If the contract involved the issuance of new shares or debt, CAP would be considered, but here it is a sales contract. Therefore, RNS is the best fit as a general material disclosure.
2022-03-22 Polish
Informacja o dopuszczeniu i wprowadzeniu do obrotu giełdowego 8.500 akcji serii E BIOMAXIMA S.A. - Content (PL)
Delisting Announcement Classification · 99% confidence The document text is very short (770 characters) and announces a decision by the Warsaw Stock Exchange Management Board (Zarząd Giełdy Papierow Wartosciowych w Warszawie S.A.) regarding the admission and introduction of 8,500 new shares (Series E) into public trading, effective March 21, 2022. This action relates to the listing of new shares, which falls under capital structure changes or share issuance. Since the document is an announcement about the listing/introduction of shares rather than a comprehensive report, and it deals specifically with the introduction of new shares into trading, the most appropriate category is 'Share Issue/Capital Change' (SHA). It is not a general regulatory filing (RNS) because a more specific category exists, and it is not a Report Publication Announcement (RPA) because it is the primary announcement of the event itself, not just the publication of an attached report.
2022-03-16 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.